Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Congenital hypothyroidism due to mutations in the sodium/iodide symporter. Identification of a nonsense mutation producing a downstream cryptic 3' splice site.
Pohlenz J
,
Rosenthal IM
,
Weiss RE
,
Jhiang SM
,
Burant C
,
Refetoff S
.
???displayArticle.abstract???
A 12-yr-old hypothyroid girl was diagnosed at birth as athyreotic because her thyroid gland could not be visualized by isotope scanning. Goiter development due to incomplete thyrotropin suppression, a thyroidal radioiodide uptake of < 1%, and a low saliva to plasma ratio of 2.5 suggested iodide (I-) transport defect. mRNA isolated from her thyroid gland and injected into Xenopus oocytes failed to increase I- transport. Sequencing of the entire Na+/I- symporter (NIS) cDNA revealed a C to G transversion of nucleotide (nt) 1146 in exon 6, resulting in a Gln 267 (CAG) to Glu (GAG) substitution. This missense mutation produces an NIS with undetectable I- transport activity when expressed in COS-7 cells. Although only this missense mutation was identified in thyroid and lymphocyte cDNA, genotyping revealed that the proposita and her unaffected brother and father were heterozygous for this mutation. However, amplification of cDNA with a primer specific for the wild-type nt 1146 yielded a sequence lacking 67 nt. Genomic DNA showed a C to G transversion of nt 1940, producing a stop codon as well as a new downstream cryptic 3' splice acceptor site in exon 13, responsible for the 67 nt deletion, frameshift, and premature stop predicting an NIS lacking 129 carboxy-terminal amino acids. This mutation was inherited from the mother and present in the unaffected sister. Thus, although the proposita is a compound heterozygote, because of the very low expression (< 2.5%) of one mutant allele, she is functionally hemizygous for an NIS without detectable bioactivity.
Abramowicz,
Familial congenital hypothyroidism due to inactivating mutation of the thyrotropin receptor causing profound hypoplasia of the thyroid gland.
1997, Pubmed
Abramowicz,
Familial congenital hypothyroidism due to inactivating mutation of the thyrotropin receptor causing profound hypoplasia of the thyroid gland.
1997,
Pubmed
Bikker,
Identification of five novel inactivating mutations in the human thyroid peroxidase gene by denaturing gradient gel electrophoresis.
1995,
Pubmed
Burant,
Mammalian facilitative glucose transporters: evidence for similar substrate recognition sites in functionally monomeric proteins.
1992,
Pubmed
,
Xenbase
Dai,
Cloning and characterization of the thyroid iodide transporter.
1996,
Pubmed
,
Xenbase
FEDERMAN,
Some observations on cretinism and its treatment.
1958,
Pubmed
Fujiwara,
Congenital hypothyroidism caused by a mutation in the Na+/I- symporter.
1997,
Pubmed
Gruters,
Congenital hypothyroidism.
1992,
Pubmed
Harden,
The salivary iodide trap in nontoxic goiter.
1968,
Pubmed
Hasegawa,
Single exon mutation in arylsulfatase A gene has two effects: loss of enzyme activity and aberrant splicing.
1994,
Pubmed
Hayashi,
Mutations of CpG dinucleotides located in the triiodothyronine (T3)-binding domain of the thyroid hormone receptor (TR) beta gene that appears to be devoid of natural mutations may not be detected because they are unlikely to produce the clinical phenotype of resistance to thyroid hormone.
1994,
Pubmed
Hayashizaki,
Deoxyribonucleic acid analyses of five families with familial inherited thyroid stimulating hormone deficiency.
1990,
Pubmed
Ishikawa,
Sequence-based typing of HLA-A2 alleles using a primer with an extra base mismatch.
1995,
Pubmed
Kajihara,
Exon redefinition by a point mutation within exon 5 of the glucose-6-phosphatase gene is the major cause of glycogen storage disease type 1a in Japan.
1995,
Pubmed
Maquat,
Defects in RNA splicing and the consequence of shortened translational reading frames.
1996,
Pubmed
Martín,
Defects in Na+/glucose cotransporter (SGLT1) trafficking and function cause glucose-galactose malabsorption.
1996,
Pubmed
,
Xenbase
Martín,
Compound missense mutations in the sodium/D-glucose cotransporter result in trafficking defects.
1997,
Pubmed
,
Xenbase
Medeiros-Neto,
Defective thyroglobulin synthesis and secretion causing goiter and hypothyroidism.
1993,
Pubmed
Medeiros-Neto,
Partial defect of iodide trapping mechanism in two siblings with congenital goiter and hypothyroidism.
1972,
Pubmed
Nakai,
Construction of a novel database containing aberrant splicing mutations of mammalian genes.
1994,
Pubmed
Pomponio,
Profound biotinidase deficiency caused by a point mutation that creates a downstream cryptic 3' splice acceptor site within an exon of the human biotinidase gene.
1997,
Pubmed
Shapiro,
RNA splice junctions of different classes of eukaryotes: sequence statistics and functional implications in gene expression.
1987,
Pubmed
Smanik,
Cloning of the human sodium lodide symporter.
1996,
Pubmed
Smanik,
Expression, exon-intron organization, and chromosome mapping of the human sodium iodide symporter.
1997,
Pubmed
Toublanc,
Comparison of epidemiological data on congenital hypothyroidism in Europe with those of other parts in the world.
1992,
Pubmed
Turk,
Membrane topology of the human Na+/glucose cotransporter SGLT1.
1996,
Pubmed
,
Xenbase
Vilijn,
Expression of the thyroid sodium/iodide symporter in Xenopus laevis oocytes.
1989,
Pubmed
,
Xenbase
Wakamatsu,
A novel exon mutation in the human beta-hexosaminidase beta subunit gene affects 3' splice site selection.
1992,
Pubmed
Weiss,
Iodide transport in a continuous line of cultured cells from rat thyroid.
1984,
Pubmed
Weiss,
Identical mutations in unrelated families with generalized resistance to thyroid hormone occur in cytosine-guanine-rich areas of the thyroid hormone receptor beta gene. Analysis of 15 families.
1993,
Pubmed